IRIS
PALOMBA, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.920
NA - Nord America 2.448
EU - Europa 1.993
SA - Sud America 532
AF - Africa 92
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.990
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.346
SG - Singapore 1.658
RU - Federazione Russa 1.186
CN - Cina 642
BR - Brasile 429
HK - Hong Kong 260
VN - Vietnam 191
IT - Italia 183
DE - Germania 134
NL - Olanda 109
FI - Finlandia 89
SE - Svezia 81
IE - Irlanda 62
CA - Canada 51
GB - Regno Unito 43
UA - Ucraina 42
IN - India 39
AR - Argentina 37
MX - Messico 35
EC - Ecuador 27
BD - Bangladesh 26
ZA - Sudafrica 25
CI - Costa d'Avorio 24
ID - Indonesia 17
PL - Polonia 17
TR - Turchia 13
CO - Colombia 12
IQ - Iraq 11
JP - Giappone 11
ES - Italia 10
FR - Francia 8
PE - Perù 8
UZ - Uzbekistan 8
DZ - Algeria 7
KZ - Kazakistan 7
MA - Marocco 7
PY - Paraguay 7
BE - Belgio 6
LT - Lituania 6
PK - Pakistan 6
KR - Corea 5
AZ - Azerbaigian 4
TN - Tunisia 4
VE - Venezuela 4
CL - Cile 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KE - Kenya 3
KG - Kirghizistan 3
NG - Nigeria 3
PH - Filippine 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
BS - Bahamas 2
CG - Congo 2
IL - Israele 2
JM - Giamaica 2
MD - Moldavia 2
MU - Mauritius 2
MW - Malawi 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SA - Arabia Saudita 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CR - Costa Rica 1
DJ - Gibuti 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
KI - Kiribati 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
MZ - Mozambico 1
PS - Palestinian Territory 1
RO - Romania 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TL - Timor Orientale 1
TZ - Tanzania 1
Totale 7.989
Salva come PNG Salva come JPEG
Città #
Singapore 684
Chandler 308
Moscow 287
Hong Kong 259
Beijing 218
Millbury 168
Ashburn 159
Santa Clara 128
Princeton 114
Nanjing 105
Amsterdam 102
Naples 85
Ho Chi Minh City 72
Jacksonville 68
Los Angeles 66
Wilmington 56
Dallas 53
Des Moines 45
São Paulo 44
The Dalles 42
New York 40
Munich 38
Hanoi 35
Seattle 35
Buffalo 33
Nanchang 30
Helsinki 26
Mexico City 25
Redondo Beach 25
San Jose 24
Boston 23
Jiaxing 21
Shenyang 21
Tianjin 21
Hefei 19
Hebei 18
Ottawa 17
Chennai 15
Dublin 15
Montreal 15
Rio de Janeiro 15
Brooklyn 14
Changsha 14
Falkenstein 14
Warsaw 14
Brasília 13
Stockholm 13
Chicago 12
Napoli 12
Turku 12
Atlanta 11
Denver 11
Toronto 11
Johannesburg 10
Phoenix 10
Rome 10
Tokyo 10
Woodbridge 10
Dong Ket 8
London 8
Norwalk 8
San Francisco 8
Curitiba 7
Da Nang 7
Guayaquil 7
Washington 7
Biên Hòa 6
Cape Town 6
Cuenca 6
Frankfurt am Main 6
Haiphong 6
Orem 6
Sorocaba 6
Tashkent 6
Boardman 5
Fortaleza 5
Guarulhos 5
Houston 5
Joinville 5
Kronberg 5
Poplar 5
Porto Alegre 5
Pune 5
Quito 5
Salvador 5
Thái Nguyên 5
Yellow Springs 5
Ankara 4
Baku 4
Belo Horizonte 4
Campinas 4
Casandrino 4
Dhaka 4
Guangzhou 4
Hải Dương 4
Kunming 4
Lahore 4
Lanzhou 4
Lima 4
Milwaukee 4
Totale 4.000
Salva come PNG Salva come JPEG
Nome #
A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: A focus on the quality of life 159
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 146
Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 138
Cardiopulmonary impairment in young women with polycystic ovary syndrome 130
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 125
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. 125
Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome 123
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 117
A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes 115
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 114
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 114
Lifestyle changes in the management of adulthood and childhood obesity. 110
Effects of neridronate treatment in elderly women with osteoporosis 108
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. 108
Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome. 108
Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: Relationship with Bsml vitamin D receptor genotypes 106
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in young women with polycystic ovary syndrome. 104
Evidence for altered adipocyte function in polycystic ovary syndrome 104
EFFECTS OF PHYSICAL EXERCISE ON THE FEMALE REPRODUCTIVE SYSTEM. 104
Cardiovascular complications of obesity in adolescents 103
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters 101
Metabolic and cardiovascular consequences of polycystic ovary syndrome 101
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome 101
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. 100
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 97
Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women 96
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial 95
Cardiovascular risk in women with polycystic ovary sydrome 94
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 94
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies 94
Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome 92
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies 90
Endothelial dysfunction in PCOS: role of obesity and adipose hormones 90
Adiponectin levels in women with polycystic ovary syndrome 89
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 88
Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. 87
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome 84
Circulating ghrelin concentrations in the polycystic ovary syndrome 84
Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: A prospective, randomized, controlled study 84
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome 83
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 82
A randomized controlled trial comparing three single-incision minislings for stress urinary incontinence 80
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study 80
A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: short-term outcomes 80
Polycystic ovary syndrome and obesity: non pharmacological approaches 76
Effect of different doses of progestin on uterine leiomyomas in postmenopausal women 76
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination 76
Short-term administration of tibolone plus GnRH analog before laparoscopic myomectomy 73
Presurgical assessment of intraabdominal visceral fat in obese patients with early-stage endometrial cancer treated with laparoscopic approach: Relationships with early laparotomic conversions 71
Laparoscopic burch colposuspension: A randomized controlled trial comparing two transperitoneal surgical techniques 71
Effectiveness of presacral neurectomy in women with severe dysmenorrhea caused by endometriosis who were treated with laparoscopic conservative surgery: A 1-year prospective randomized double-blind controlled trial 70
Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas 70
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 68
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 67
Single-incision Mini-slings Versus Retropubic Tension-free Vaginal Tapes: A Multicenter Clinical Trial 67
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 67
Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women 65
Effect of tibolone on breast symptoms resulting from postmenopausal hormone replacement therapy 64
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 64
Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome 63
Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial 62
Laparoscopic colposuspension using sutures or prolene meshes: A 3-year follow-up 62
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 62
Long-term Effectiveness of Presacral Neurectomy for the Treatment of Severe Dysmenorrhea Due to Endometriosis 62
Bupivacaine plus epinephrine for laparoscopic myomectomy: A randomized placebo-controlled trial 61
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 60
Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy 60
Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy 59
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 59
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 59
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 58
Laparoscopic uterine nerve ablation versus vaginal uterosacral ligament resection in postmenopausal women with intractable midline chronic pelvic pain: A randomized study 57
Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study 56
Randomized Controlled Study Comparing the Gynecare Morcellex and Rotocut G1 Tissue Morcellators 56
Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-γ Polymorphisms in Polycystic Ovary Syndrome 54
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study 53
Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study 52
Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women 50
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 50
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial 50
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism 49
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis 49
Visceral fat amount as predictive factor for early laparotomic conversion in obese patients with endometrial cancer 49
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome 49
Raloxifene administration in premenopausal women with uterine leiomyomas: A pilot study 49
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: A comprehensive review 49
Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone 48
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene 47
GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome 47
Updating of a recent meta-analysis of randomized controlled trials to assess the safety and the efficacy of the laparoscopic surgery for treating early stage endometrial cancer 47
What is the best first-step therapeutic approach in treating anovulatory infertility in patients with polycystic ovary syndrome? Questions that are still unanswered 47
Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome 47
Two techniques of laparoscopic retropubic urethropexy 46
Does raloxifene inhibit the growth of uterine fibroids? [10] (multiple letters) 43
Lack of an association between peroxisome proliferator-activated receptor-γ gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 42
Ovulation induction in women with polycystic ovary syndrome 41
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 40
Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance 40
Laparoscopy or minilaparotomy as minimally invasive surgical approach for uterine leiomyomas? An unsolved question 39
Lipid profile in nonobese pregnant women with polycystic ovary syndrome: A prospective controlled clinical study 38
Totale 7.683
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 0 10 1 9 2 8 9
2021/2022600 5 0 0 4 9 54 2 25 53 57 109 282
2022/2023753 123 57 22 64 88 72 11 57 110 91 48 10
2023/2024449 21 84 110 26 18 26 0 42 4 2 67 49
2024/20252.563 132 114 21 23 43 211 259 177 195 261 907 220
2025/20263.015 586 446 474 425 826 230 28 0 0 0 0 0
Totale 8.131